Treatment with Livmarli (maralixibat) leads to significant clinical benefits for people with progressive familial intrahepatic cholestasis (PFIC) across…
Articles by Lindsey Shapiro, PhD
Global rates for evaluating chronic hepatitis B and starting appropriate treatment are lower than they should be, especially among…
Daily treatment with Bylvay (odevixibat) safely and effectively eases itching and lowers blood bile acid levels, a sign of liver…
Throughout May, the U.S. Centers for Disease Control and Prevention (CDC) will work with public health partners to raise…
Gilead Sciences has awarded $4 million in funding via its ALL4LIVER grant program to organizations worldwide whose community-based efforts…
FXR314, an investigational oral therapy, safely and effectively reduced liver fat content in adults with a severe form of…
The approval of Rezdiffra (resmetirom) last month in the U.S. as the first ever treatment for nonalcoholic steatohepatitis (NASH),…
Five-year-old Sadie Sellers, who was born with biliary atresia, is the focus of a fundraising event designed to raise…
Elafibranor, an oral molecule under regulatory review as a new second-line treatment for adults with primary biliary cholangitis (PBC),…
Chiglitazar (carfloglitazar), an oral medication approved to treat type 2 diabetes in China, led to significant reductions in liver fat…